Large Study Shows Eating Better at Any Age Can Prolong Life

Share this content:
Large Study Shows Eating Better at Any Age Can Prolong Life
Large Study Shows Eating Better at Any Age Can Prolong Life

THURSDAY, July 13, 2017 (HealthDay News) -- Sustained diet changes -- even later in life -- can extend people's lives, according to research published in the July 13 issue of the New England Journal of Medicine.

The findings are based on 73,739 U.S. health professionals who were part of two long-running studies that began in the 1970s and 1980s. Between 1998 and 2010, almost 10,000 of those study participants died. Mercedes Sotos-Prieto, Ph.D., a visiting scientist at the Harvard School of Public Health in Boston, and colleagues looked at how people's risk of early death related to any diet changes they'd made in the previous 12 years (1986 to 1998). The researchers used three scoring systems: the Alternate Healthy Eating Index; the Alternate Mediterranean Diet score; and the DASH (Dietary Approaches to Stop Hypertension) diet score.

Overall, the researchers found, a 20-percentile improvement in diet quality was linked to an 8 to 17 percent decrease in the risk of early all-cause mortality. There was a similar decrease in the risk of dying from cardiovascular disease or stroke, specifically.

"Improved diet quality over 12 years was consistently associated with a decreased risk of death," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths